Annexin Pharmaceuticals AB (publ) is a world-leading biotechnology company.
Annexin Pharmaceuticals has raised $674K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2022.
Annexin Pharmaceuticals is headquartered in Stockholm, Sweden.
Annexin Pharmaceuticals AB (publ) is a world-leading biotechnology company.
Annexin Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Annexin Pharmaceuticals — Funding & Investors." VCBacked, December 19, 2022, https://www.vcbacked.co/company/annexin-pharmaceuticals. Accessed August 15, 2026.
VCBacked. (2022). Annexin Pharmaceuticals — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/annexin-pharmaceuticals
{{cite web |title=Annexin Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/annexin-pharmaceuticals |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated